Performance-Based Risk-Sharing Arrangements: An Updated International Review

被引:0
|
作者
Josh J. Carlson
Shuxian Chen
Louis P. Garrison
机构
[1] University of Washington,Pharmaceutical Outcomes Research and Policy Program
来源
PharmacoEconomics | 2017年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Enthusiasm for performance-based risk-sharing arrangements (PBRSAs) continues but at variable pace across countries. Our objective was to identify and characterize publicly available cases and related trends for these arrangements. We performed a review of PBRSAs from 1993 to 2016 using the University of Washington PBRSA Database. Arrangements were categorized according to a previously published taxonomy. Macro-level trends were identified related to the timing of adoption, countries involved, types of arrangements, and disease areas. Our search yielded 437 arrangements. Among these, 183 (41.9%) were categorized as currently active, while 58.1% have expired. Five main types of arrangements have been identified, namely coverage with evidence development (149 cases, 34.1%), performance-linked reimbursement (104 cases, 23.8%), conditional treatment continuation (78 cases, 17.8%), financial or utilization (71 cases, 16.2%), and hybrid schemes with multiple components (35 cases, 8.0%). The pace of adoption varies across countries but has renewed an upward trend after a lull in 2012/2013. Conditions in the USA may be changing toward a more favorable environment of PBRSAs. Interest in PBRSAs remains high, suggesting they are a viable coverage and reimbursement mechanism for a wide range of medical products.
引用
收藏
页码:1063 / 1072
页数:9
相关论文
共 50 条
  • [1] Performance-Based Risk-Sharing Arrangements: An Updated International Review
    Carlson, Josh J.
    Chen, Shuxian
    Garrison, Louis P., Jr.
    [J]. PHARMACOECONOMICS, 2017, 35 (10) : 1063 - 1072
  • [2] Emerging roles for pharmacists in performance-based risk-sharing arrangements
    Calabrese, Martin J.
    Cooke, Catherine E.
    Watson, Kristin
    de Bittner, Magaly Rodriguez
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (13) : 1007 - 1012
  • [3] Performance-based risk-sharing arrangements for devices and diagnostics in the United States: a systematic review
    Chen, Yilin
    Carlson, Josh J.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (01): : 78 - 83
  • [4] PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS IN DIAGNOSTICS AND DEVICES IN THE UNITED STATES
    Chen, Y.
    Carlson, J.
    [J]. VALUE IN HEALTH, 2021, 24 : S238 - S238
  • [5] When do performance-based risk-sharing arrangements make sense?
    Drummond, Michael
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (06): : 569 - 571
  • [6] International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market
    Xu, Weiwei
    Wu, Jing
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (05) : 486 - 491
  • [7] When do performance-based risk-sharing arrangements make sense?
    Michael Drummond
    [J]. The European Journal of Health Economics, 2015, 16 : 569 - 571
  • [8] Performance-Based Risk-Sharing Arrangements-Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
    Garrison, Louis P., Jr.
    Towse, Adrian
    Briggs, Andrew
    de Pouvourville, Gerard
    Grueger, Jens
    Mohr, Penny E.
    Severens, J. L.
    Siviero, Paolo
    Sleeper, Miguel
    [J]. VALUE IN HEALTH, 2013, 16 (05) : 703 - 719
  • [9] Performance-based risk-sharing arrangements for devices and procedures in cardiac electrophysiology: an innovative perspective
    Boriani, Giuseppe
    Vitolo, Marco
    Svennberg, Emma
    Casado-Arroyo, Ruben
    Merino, Jose L.
    Leclercq, Christophe
    [J]. EUROPACE, 2022, 24 (10): : 1541 - 1547
  • [10] Using Performance-Based Risk-Sharing Arrangements to Address Uncertainty in Indication-Based Pricing
    Yeung, Kai
    Li, Meng
    Carlson, Josh J.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (10): : 1010 - 1015